Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens

Nat Nanotechnol. 2023 Aug;18(8):922-932. doi: 10.1038/s41565-023-01384-5. Epub 2023 Jun 1.

Abstract

Deployment of nucleic acid amplification assays for diagnosing pathogens in point-of-care settings is a challenge due to lengthy preparatory steps. We present a molecular diagnostic platform that integrates a fabless plasmonic nano-surface into an autonomous microfluidic cartridge. The plasmonic 'hot' electron injection in confined space yields a ninefold kinetic acceleration of RNA/DNA amplification at single nucleotide resolution by one-step isothermal loop-mediated and rolling circle amplification reactions. Sequential flow actuation with nanoplasmonic accelerated microfluidic colorimetry and in conjugation with machine learning-assisted analysis (using our 'QolorEX' device) offers an automated diagnostic platform for multiplexed amplification. The versatility of QolorEX is demonstrated by detecting respiratory viruses: SARS-CoV-2 and its variants at the single nucleotide polymorphism level, H1N1 influenza A, and bacteria. For COVID-19 saliva samples, with an accuracy of 95% on par with quantitative polymerase chain reaction and a sample-to-answer time of 13 minutes, QolorEX is expected to advance the monitoring and rapid diagnosis of pathogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / diagnosis
  • Colorimetry
  • Humans
  • Influenza A Virus, H1N1 Subtype* / genetics
  • Influenza, Human*
  • Microfluidics
  • Molecular Diagnostic Techniques
  • Nucleic Acids*
  • RNA, Viral / genetics
  • SARS-CoV-2 / genetics
  • Sensitivity and Specificity

Substances

  • Nucleic Acids
  • RNA, Viral

Grants and funding